Acute ischemic stroke (AIS) affects over 800,000 individuals each year and is the leading cause of death and disability in the United States. Additionally, transient ischemic attacks (TIA), a momentary abnormal neurological episode, often comes before a stroke. A TIA increases an individual's chance of having a stroke by 20% within 90 days.
A key to stroke prevention is iodentifying the cause of the stroke. Diagnosis for AIS and TIA's are based on a combination of the patient's medical history, medical findings, and brain scans such as cat scans and MRI's. Understanding the medical causes can be helpful in defining major stroke types. By identifying the causes of major stroke types therapy can be aimed at prevention of future strokes.
The BASE trial consists of two blood tests identifying chemical changes in the blood stream. Chemical changes occur as a result of AIS or TIA. These tests are based on the chemical changes